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Abstract
Little information is available on the impact of hemodialysis on cerebral water homeostasis
and its distribution in chronic kidney disease. We used a neuropsychological test battery,
structural magnetic resonance imaging (MRI) and a novel technique for quantitative mea-
surement of localized water content using 3T MRI to investigate ten hemodialysis patients
(HD) on a dialysis-free day and after hemodialysis (2.4±2.2 hours), and a matched healthy
control group with the same time interval. Neuropsychological testing revealed mainly atten-
tional and executive cognitive dysfunction in HD. Voxel-based-morphometry showed only
marginal alterations in the right inferior medial temporal lobe white matter in HD compared
to controls. Marked increases in global brain water content were found in the white matter,
specifically in parietal areas, in HD patients compared to controls. Although the global water
content in the gray matter did not differ between the two groups, regional increases of brain
water content in particular in parieto-temporal gray matter areas were observed in HD pa-
tients. No relevant brain hydration changes were revealed before and after hemodialysis.
Whereas longer duration of dialysis vintage was associated with increased water content in
parieto-temporal-occipital regions, lower intradialytic weight changes were negatively corre-
lated with brain water content in these areas in HD patients. Worse cognitive performance
on an attention task correlated with increased hydration in frontal white matter. In conclu-
sion, long-term HD is associated with altered brain tissue water homeostasis mainly in pari-
etal white matter regions, whereas the attentional domain in the cognitive dysfunction
profile in HD could be linked to increased frontal white matter water content.
PLOS ONE | DOI:10.1371/journal.pone.0122188 March 31, 2015 1 / 18
a11111
OPEN ACCESS
Citation: Reetz K, Abbas Z, Costa AS, Gras V, Tiffin-
Richards F, Mirzazade S, et al. (2015) Increased
Cerebral Water Content in Hemodialysis Patients.
PLoS ONE 10(3): e0122188. doi:10.1371/journal.
pone.0122188
Academic Editor: Su Lui, West China Hospital of
Sichuan University, CHINA
Received: August 6, 2014
Accepted: February 10, 2015
Published: March 31, 2015
Copyright: © 2015 Reetz et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Nevertheless, the correspondence author Dr. Kathrin
Reetz can be contacted at kreetz@ukaachen.de for
further questions.
Funding: Sources of support: This work was
supported in part by the Excellence Initiative of the
German Research Foundation [DFG ZUK32/1] and
the German Federal Ministry of Education and
Research [BMBF 01GQ1402] to KR; and by a PhD
fellowship (SFRH/BD/65743 2009) from the
Fundação para a Ciência e Tecnologia (FCT),
financed by the POPH – QREN Program to ASC.
Introduction
In chronic kidney disease (CKD) patients, cognitive impairment is highly prevalent and in-
creases as kidney function worsens [1, 2]. In patients undergoing hemodialysis (HD), it
markedly exceeds values observed in age-matched controls [3, 4]. Knowledge of cerebral
changes in CKD, as well as the impact of HD on cognition and brain function is limited. Al-
though the brain and the kidneys both show a similar vulnerability to vascular damage [5],
their pathophysiological linkage is multifaceted. Both suffer damage from hypertension, diabe-
tes, hypercholesterolemia, anemia and inflammatory changes [6–8] resulting in an increased
prevalence of silent brain infarcts as well as microbleeds in CKD patients [8]. Besides cerebro-
vascular changes, a direct uremic neuronal toxicity supports additional neurodegenerative
pathways [9]. Although the cerebrovascular aspect is also supported by the neuropsychological
pattern of cognitive impairment in CKD patients, namely executive functions and psychomo-
tor speed deficits [10], memory-relevant alterations have also been reported [11]. Furthermore,
cognitive functions fluctuate over the course of the dialysis cycle and cognitive functioning is
mostly vulnerable during the dialysis session [12]. This finding suggests that direct conse-
quences of CKD such as overhydration and/or the uremic milieu may also affect cognitive
functioning [13].
Non-invasive, quantitative mapping of water content in the in vivo human brain has dem-
onstrated the ability to provide important disease-related parameters associated with focal or
global change in tissue water homeostasis [14]. We used a recently validated magnetic reso-
nance imaging (MRI) technique for quantitative water content measurement [15, 16] to inves-
tigate brain water changes in HD patients.
The aim of the study was to identify such changes in late stage CKD and possible variations
during the dialysis cycle, as well as their relation to clinical disease-specific features using a re-
cently validated whole-brain MRI sequence.
Methods
Participants
Ten patients undergoing hemodialysis in the greater Aachen area were recruited (for detailed
characteristics of the study sample please see Table 1). The control group comprised ten
healthy volunteers with no history of cardiovascular or kidney diseases matched for age, gender
and education. Exclusion criteria for all study participants included contraindications for re-
search MRI, severe sensory impairment, and previous history of neurological or psychiatric
disease. All subjects provided written informed consent for participation in this study, which
was approved by the local ethics committee of the RWTH Aachen University (EK 179/11) and
conducted in accordance to the latest version of the Helsinki declaration.
MRI and neuropsychological testing were applied at two time points: (t1) dialysis-free day
and (t2) after dialysis (mean 2.4 hours ± 2.2 standard deviation [SD] time after dialysis session
for MRI measurement). Eight of ten patients were retested within the same dialysis cycle
(24-hours time period), but due to acute intercurrent illness one patient was retested within
48 hours and one patient within one month. Healthy controls were all retested within 24 hours.
All participants received a comprehensive neuropsychological assessment including major
cognitive domains—attention, memory, executive functions, visuospatial processing and lan-
guage—, as well as screening instruments for depression and anxiety (HADS, Hospital Anxiety
and Depression Scale [17]), daytime sleepiness (Epworth Sleepiness Scale (ESS)) and fatigue
[18], as previously described by Costa et al, [19]. The Mini-Mental State Examination (MMSE)
[20] and the Montreal Cognitive Examination (MoCA) [21, 22] were used as brief cognitive
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Table 1. Demographic and clinical characteristics of the hemodialysis patients and healthy control groups.
Demographic and clinical variables Hemodialysis patients Healthy controls p-value
n = 10 n = 10
Age, years 45.80 (12.67) 50.30 (14.44) .47
Sex, % female 40 40 1
Education, years 12.00 (3.06) 14.00 (2.16) .11
CV risk factors
Diabetes 20% none .47
Hypertension 90% 20% <.05
Hypercholesterolaemia 10% none 1
Smoking, (py) 6.3 (10.2) 0 .24
BMI (km/m2) 24.7 (4.4) 23.6 (3.3) .68
Cardiovascular Risk (SCORE) 1 (1.5) - -
Charlson Comorbidity Index (CCI) 3.1 (1.7) .80 (1.1) <.01
Medication
Antihypertensives 90% 20% <.05
Insulin 20% none .47
Thyroid drugs 30% none .21
Antipsychotics 20% none .47
Antidepressants 20% none .47
Anxiolytics 10% none 1
Analgesics 10% none 1
Levodopa 10% none 1
n affecting cognition 30% none .32
Primary cause of CKD
Diabetic nephropathy 10% - -
Glomerulonephritis and systemic diseases 20% - -
Polycystic kidney disease 20% - -
Other/Unknown 20%/30% - -
CKD associated comorbidities
Renal anemia 80% - -
Secondary hyperparathyroidism 20% - -
Renovascular hypertension 40% - -
History of kidney transplant 10% - -
Dialysis parameter
Median dialysis vintage, months 44.50 - -
Median intradialytic weight change, kg -1.5 - -
Intradialytic hypotensive episodes .44 (1.0) - -
Blood values
Hematocrit (l/l) .325 (.05) - -
Hemoglobin (g/dl) 10.6 (1.9) - -
Platelets (G/l) 282.3 (90.3) - -
Leukocytes (G/l) 7.8 (2.0) - -
Sodium (mmol/l) 137.3 (3.2) - -
Potassium (mmol/l) 4.8 (1.3) - -
Urea (mg/dl) 136.9 (59.0) - -
(Continued)
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screening tools to assess global cognition. Cued and not-cued reaction times were measured
through the Alertness sub-test of the Test of Attentional Performance [23]. The Trail making
test (TMT) parts A and B [24] provided an index on processing speech and cognitive flexibility.
We measured the span of immediate verbal recall and auditory working memory through the
digit span forwards and backwards [25]. The verbal fluency task [26], with semantic and pho-
nemic modalities assesses functions related to language production, as well as executive func-
tions. The Stroop test [27] was used as a measure of selective attention and inhibitory control.
The California Verbal Learning Test (CVLT) test [28] was used for verbal episodic memory
providing measures on verbal learning, immediate and delayed recall, as well as recognition.
We used the MCGCF complex figure [29] to assess visual perception and construction (figure
copy), as well as visual memory (3-minutes immediate and 30-minutes delayed recall). To ex-
clude basal language and visual perception deficits, participants completed at baseline a short-
form of the Boston Naming Test [29] and the Incomplete Letters sub-test from the Visual Ob-
ject Spatial Perception (VOSP) battery [30].
Given the repeated-measures nature of the study alternate-forms were used, when available,
and test order and time of assessment order were controlled for (for details [19]).
A detailed medical history for all patients with the following parameters was obtained: CKD
etiology, hemodialysis vintage duration (the duration in months of the hemodialysis treatment)
and volume of hemodialysis, frequency of intradialytic hypotensive episodes, as well as the fol-
lowing routine blood work: hematocrit, hemoglobin, leukocytes, platelets, glucose, sodium, po-
tassium, urea, and creatinine. Comorbidities were quantified using the Charlson Comorbidity
Index (CCI), which predicts the ten-year mortality by weighting several comorbid conditions,
either corrected for dialysis [31] or corrected for age in the healthy control subjects [32]. The
presence of cardiovascular risk factors (CVRF)—diabetes, hypertension, hypercholesterolemia,
smoking, body mass index (BMI)—was recorded for all participants. For patients, CVRFs were
rated using the low SCORE risk charts [33]. Medication was also listed for all participants and
neuroleptics, antidepressants, opioids, as well as antiparkinsonian agents were considered as
psychoactive medication.
MRI data acquisition
MRmeasurements were performed on a 3 Tesla Trio MR scanner at the RWTH Aachen Uni-
versity (Siemens Medical Systems, Erlangen, Germany). Radio frequency (RF) excitation and
signal reception were achieved with a body coil and a 32-channel receive phased array head
coil, respectively. Quantitative cerebral water content measurements were based on the estima-
tion of the MR-visible proton density (PD) [14, 16, 34–40]. It is indeed well accepted that the
MR-visible proton density (PD) provides a very reliable measure of free water content present
in the tissue [41]. A rough estimate of the MR-visible PD was obtained using a standard multi-
slice, multi-echo Gradient Recalled Echo (GRE) MRI sequence (TR = 1800ms, TE = 5.2ms and
Table 1. (Continued)
Demographic and clinical variables Hemodialysis patients Healthy controls p-value
n = 10 n = 10
Creatinine (mg/dl) 9.7 (4.1) - -
All data shown as mean (SD), except where noted. Charlson Comorbidity Index (CCI) corrected for dialysis patients and corrected for age in the control
group. CV = Cerebrovascular; py = pack years; CKD = Chronic kidney disease. Other causes include progression of CKD due to post-operative infections,
reflux diseases, analgesic medication.
doi:10.1371/journal.pone.0122188.t001
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FA = 40°), below referred to as the PD scan. Subsequently, the following transformations were
applied on the PD scan prior to data analysis [16, 34, 40]: i) compensation of the transmit (B1
+)
and receive field (B1
-) inhomogeneity ii) compensation of the T2 decay and iii) correction of
the T1-saturation effect iv) correction of residual nonuniformity and v) normalization of the
image to the ventricular cerebrospinal fluid (CSF) signal to obtain the water molarity (mol/L)
of the tissue, expressed as a percentage of pure water molarity. The steps i) to iii) necessitate
the inclusion of additional MRI scans into the water content protocol, namely, a second GRE
scan (TR = 500ms, TE = 5.2ms and FA = 90°) for estimating T1 and applying the T1-saturation
correction, a series of four single-shot GRE-EPI scans (TE = 11ms and FA = 30°, 60°, 90°, 120°)
for estimating B1
+ and a set of two low-resolution GRE scans (TR = 500ms, TE = 5.2ms and
FA = 40°) for obtaining B1
- (Abbas et al., 2014). Finally, a multi-echo 3D-GRE MR acquisition
was performed (TR = 35ms, FA = 12°, TE1 = 2.3ms, ΔTE = 2.27ms, 8 echoes). It allows estimat-
ing the T2 decay constant and correct for the signal decay for the first echo image of the PD-
scan. The PD-scan consisted of 64 transverse slices, read in two interleaved concatenations (re-
sulting in a gap free acquisition). The readout direction was anterior-posterior and the phase
field-of-view (FOV) was adjusted to contain the entire brain (typically 190 mm). The sequences
for mapping T1, T2, B1
+, B1
- were adjusted to the same slice orientation and FOV as the PD-
scan. Parallel imaging was employed with the generalized auto-calibrating partially parallel ac-
quisition (GRAPPA) technique [42] with an acceleration factor of two, which allowed shorten-
ing significantly the acquisition time. The total scan time for the water mapping protocol was
fourteen minutes.
In addition to the water content protocol, a high-resolution T1-weighted image was ac-
quired using a magnetization-prepared rapid gradient-echo sequence (MPRAGE) with
TR = 1900ms, TE = 2.52ms, TI = 900ms, FoV = 250mm, 256x256 matrix, 176 sagittal slices,
slice thickness = 1mm, resulting in an acquisition time of five minutes.
Voxel-Based Morphometry (VBM) analysis
To investigate the structural differences between HD patients and controls, the MPRAGE data-
sets were analyzed using the Statistical Parametric Mapping toolbox (SPM8, www.fil.ion.ucl.ac.
uk/spm) and the voxel-based-morphometry toolbox (VBM8, http://dbm.neuro.uni-jena.de/
vbm). Applying a standard VBM approach [43], the MPRAGE images were spatially normal-
ized by high-dimensional warping with a standard template and segmented into gray matter
(GM), white matter (WM) and cerebrospinal fluid (CSF). To correct for individual brain sizes
and to allow the comparison of the absolute amount of tissue volume, voxel values were multi-
plied (modulated) by the non-linear component of the Jacobian determinant derived from the
spatial normalization. Finally, modulated gray matter and white matter images were smoothed
with a kernel of 12 mm Gaussian full width at half maximum (FWHM). Gray matter and white
matter differences between patients and controls were tested using two-sample t-tests, includ-
ing age as a nuisance covariate. Results were accessed at highest threshold of P< 0.05 (family
wise error [FWE]-corrected) across the whole brain and by using minimum cluster size (kE) of
80 voxels. Coordinates are reported in the standard anatomical space developed at the Mon-
treal Neurological Institute (MNI).
Global and focal analyses of quantitative brain water content
To analyze cerebral water content changes within the brain, the MPRAGE and the quantitative
PD and T1 images delivered by the quantitative water content protocol were normalized to
MNI template for each individual (1mm isotropic MNI152 T1–weighted), using the FSL-tool
FLIRT (http://www.fmrib.ox.ac.uk/fsl), with a 12-parameter affine transformation [44].
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Subsequently, the MPRAGE image was segmented into gray and white matter as well as cere-
brospinal fluid using SPM8 segmentation [45]. In order to efficiently suppress the influence of
partial volume effects, all voxels with gray and white matter as well as cerebrospinal fluid prob-
abilities smaller than one were set to zero [46].
Histograms of the MR parameters of interest (PD and T1) were computed after brain vol-
ume segmentation. In order to estimate the PD and T1 values in white matter and gray matter,
discriminant analyses for the bivariate histogram of (PD, T1) were performed using the MIX-
MOD software package which allows performing model-based classifications of qualitative and
quantitative data (http://mixmod.org) [47]. Furthermore, global differences between HD pa-
tients and healthy controls groups were assessed using non-parametric Wilcoxon rank-
sum test.
For the purpose of focal sub-analyses, several ROIs were selected from the MNI standard
template (probability threshold of 75% or above was used for masking) to compute the mean
values and standard deviations of water content and T1, separately for white matter and gray
matter. The following ROIs, obtained from the MNI atlas [48], Harvard-Oxford cortical and
subcortical structural atlas [49–52], were used for further screening and partitioning in an ex-
ploratory manner to quantify cerebral water content: total intracranial volume, total white mat-
ter, total gray matter, frontal, temporal, parietal and occipital cortices, caudate, putamen,
thalamus, globus pallidus, para- and hippocampus, corpus callosum (body), insula, brainstem,
cingulum (anterior cingulate, angular cortex, posterior cingulate cortex), cerebellum, superior
frontal gyrus, middle frontal gyrus, inferior frontal gyrus (pars triangularis and pars opercu-
laris), superior temporal gyrus, middle temporal gyrus, inferior temporal gyrus, superior parie-
tal lobule gyrus, operculum (frontal, central and parietal), precuneus, lateral occipital cortex
(superior, inferior division), supracalcarine cortex and occipital pole.
In order to report water content from mixed gray and white matter brain structures (e.g.,
angular gyrus with 50% gray matter and 49% white matter), the atlas-based ROI masks were
multiplied by the subject specific gray or white matter mask so as to report white matter or
gray matter water content value for such region. This analysis concerned only structures having
more than 7% gray or white matter tissues. Only significant changes in cerebral tissue water
homeostasis are reported.
Statistical analysis
Depending on the comparison and respective test assumptions, group differences based on de-
mographic and clinical variables were reported using the independent-sample T test, Mann-
Whitney or the X2 test. Accounting for missing data, we calculated linear mixed models with
random effects for correlated data, with education and testing order as covariates, to determine
group, time and interaction of group and time effects on cognitive performance and in the re-
gional water content. The goodness-of-fit and the normality of the residuals were verified. As-
sociation measures between clinical and cognitive data (at baseline) and water mapping data
were performed by computing Person’s (r) or Spearman’s [53] correlation coefficients, with a
significance threshold of 0.05. Effect sizes were calculated using Cohen’s d test [54] (0.3 small,




Neuropsychological performance of HD patients and healthy controls, before and after dialysis,
are reported in Table 2, HD patients performed consistently worse than matched healthy
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Table 2. Neuropsychological performance of hemodialysis patients and healthy controls on t1 and t2 time-points.
Cognitive Domain/Test Hemodialysis Patients (n = 10) Healthy Controls (n = 10)
t1 t2 t1 t2
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mixed Model
Screening
MoCA (total score) 24.00 (2.67) 24.00 (4.0) 26.90 (1.97) 27.7 (1.25) g**
MMSE (total score) 24.57 (10.8) 28.83 (1.17) 29.00 (.87) 28.98 (1.45) ns
Attention
Phasic Alertness (msec.) 248.99 (38.70) 286.75 (59.87) 240.00 (35.49) 228.8 (36.49) i*
Intrinsic Alertness (msec.) 251.13 (32.19) 290.00 (54.40) 231.00 (24.89) 218.50 (26.42) i*
Verbal Memory
Digit span forwards 6.86 (1.07) 7.00 (1.55) 8.60 (1.84) 7.00 (1.55) g*
CVLT Total learning 51.71 (5.16) 51.67 (9.67) 55.10 (10.65) 52.80 (13.05) ns
CVLT Interference 5.14 (1.68) 4.67 (2.42) 6.50 (2.76) 6.40 (2.46) ns
CVLT Immediate recall 10.29 (3.15) 9.17 (3.32) 12.10 (3.25) 11.70 (3.16) i**
CVLT Delayed recall 11.00 (2.08) 10.5 (3.02) 12.60 (2.50) 12.00 (3.13) ns
CVLT Recognition 15.57 (.79) 15.67 (.52) 15.60 (.52) 15.60 (.69) ns
Nonverbal Memory
Complex Figure Immediate recall 20.86 (6.29) 22.00 (6.36) 26.55 (6.65) 23.39 (9.28) ns
Complex Figure delayed recall 19.33 (6.38) 21.50 (6.89) 24.39 (8.14) 23.28 (9.99) ns
Visuospatial functions
Complex Figure Copy 31.14 (2.73) 31.33 (2.81) 33.50 (2.32) 33.0 (2.28) g*
VOSP Incomplete Letters 19.57 (.79) - 19.00 (.83) - ns
Language
Boston Naming Test 14.43 (.79) - 14.90 (.32) - ns
Executive Functions
Digit span backwards 5.86 (.90) 5.67 (1.63) 6.70 (1.16) 5.67 (1.63) g**
Semantic verbal fluency 25.43 (7.44) 25.00 (8.69) 33.70 (6.06) 31.00 (8.86) g**
Phonemic verbal fluency 11.57 (4.54) 12.50 (1.52) 22.60 (7.53) 22.30 (8.83) g***
TMT A (sec.) 54.29 (30.38) 46.5 (22.6) 28.40 (8.48) 24.70 (6.95) g*
TMT B (sec.) 141.33 (94.58) 170.5 (132.73) 60.9 (14.29) 66.10 (32.15) g*
Stroop Reading (sec.) 34.83 (10.84) 37.00 (12.02) 31.10 (3.07) 29.70 (4.08) ns
Stroop Naming (sec.) 60.17 (15.07) 56.00 (10.67) 49.4 (8.21) 46.70 (8.37) ns
Stroop Interference (sec.) 115.67 (50.47) 116.17 (58.46) 82.5 (19.10) 75.10 (15.24) ns
HADS
Anxiety 5.67 (4.58) - 1.40 (1.58) - ns
Depression 2.78 (2.49) - .70 (1.25) - §**
Fatigue 5.17 (2.40) 5.67 (1.75) .75 (.96) .50 (.58) g***
Sleepiness (ESS) 7.00 (2.49) - 5.90 (3.32) - ns
Note. MoCA total score corresponds to the total uncorrected score; MoCA = Montreal Cognitive Assessment, MMSE = Mini-mental State Examination,
CVLT = California Verbal Learning Test, VOSP = Visual Object and Space Perception Battery, TMT = Trail Making Test, HADS = Hospital Anxiety and
Depression Scale; ESS = Epworth Sleepiness Scale. ns, not significant; i, significant interaction of group and time; g, significant main effect of group; §
significant Wilcoxon-Mann–Whitney U test, with Bonferroni correction for multiple testing (p <.01). Mixed linear model Group x Time, with education and
presentation order as covariates.
* p <. 05
** p <. 01
*** p <. 001.
doi:10.1371/journal.pone.0122188.t002
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controls in several cognitive domains, especially in attention (phasic and intrinsic alertness,
digit span) and executive functions (verbal fluency, working memory, cognitive flexibility). We
found no differences between groups regarding verbal and nonverbal memory functions, nor
basal language and visuospatial functioning. We found an interaction effect of dialysis on the
phasic and intrinsic alertness and immediate verbal recall performance, where patients showed
a decline in performance after dialysis, whereas controls showed an improvement in perfor-
mance at re-test. Patients presented with higher levels of fatigue, which remained stable around
the dialysis cycle. They also scored significantly higher for anxiety and total HADS score when
compared to controls.
Voxel-based morphometry (VBM) of white and gray matter
VBM analysis revealed no significant differences in gray matter and white matter volume when
comparing HD patients to healthy controls, apart from one cluster of 96 voxels in the white
matter of the right inferior medial temporal lobe (x = 34, y = 4, z = -36, Z = 4.78). There were
no differences in gray and white matter between measurements t1 and t2. However, total brain
tissue volume was 7% lower in HD patients compared to controls.
Brain water content analysis
The quantitative water content maps (Fig 1) (an overlaid p-value map on a MNI template) and
the histograms (Fig 2) show that the spatial distribution of the estimated brain water content
was altered predominantly in the white matter (p = 0.03, d = 0.98) in HD patients as compared
to controls (Table 3). Whereas increased brain water content in white matter was found in the
frontal (p = 0.03, d = 0.96), temporal (p = 0.04, d = 0.90), parietal (p = 0.02, d = 1.14) and occip-
ital (p = 0.03, d = 0.95) lobes, gray matter water content was only affected in temporal
(p = 0.04, d = 0.56) and parietal lobes (p = 0.04, d = 0.94). No within-group changes in brain
hydration were found for the HD and control groups before and after dialysis. Whereas, greater
brain water content values in HD patients compared to controls group were found in the larg-
est white matter bundle, the corpus callosum. Regarding the frontal lobe, increased brain water
content was found in the frontal white matter (inferior frontal gyrus, operculum cortex) and
gray matter regions (frontal pole, inferior frontal gyrus pars triangularis). The white matter in
the temporal lobe showed increased water content in the superior temporal gyrus, middle tem-
poral gyrus, inferior temporal gyrus and the hippocampus as well as in gray matter tissue in the
superior temporal gyrus, fusiform cortex, temporal pole, and hippocampus. However, the
major increase of water content alterations was revealed in the parietal lobe (large effect size),
in the white matter (postcentral gyrus, parietal operculum, supramarginal gyrus, angular gyrus,
intracalcarine cortex) and in the gray matter (supramarginal gyrus, angular gyrus, parietal
operculum cortex, supracalcarine cortex). Increased occipital water content was found in the
lateral occipital cortex and in the occipital pole. In the remaining regions the differences be-
tween HD patients and controls were not statistically significant regarding time and group
using the mixed linear model.
Association with demographic, clinical parameters and cognitive
performance
Association measures showed that the duration of dialysis vintage (Fig 3A) was positively cor-
related with the water content observed in the parietal white matter (r = 0.69, p<0.05), in the
parietal gray matter (r = 0.91, p<0.05), in the temporal gray matter (r = 0.89, p<0.05) and in
the occipital gray matter (r = 0.88, p<0.05). The intradialytic weight change (3B) during the di-
alysis cycle was negatively correlated with parietal white matter water content (r = -0.74,
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p<0.01), in particular the precuneus (r = -0.71, p<0.05), occipital white matter (r = -0.68,
p<0.05) and the body of the corpus callosum (r = -0.72, p<0.05). Furthermore, intradialytic
weight change was negatively associated with parietal gray matter (r = -0.861, p<0.05), tempo-
ral gray matter (r = -0.71, p<0.05) and occipital gray mater water content (r = -0.81, p<0.01).
Intrinsic alertness was positively correlated with frontal white matter water content (r = 0.73,
p<0.05). We also found negative moderate to good correlation coefficients between the score
on the anxiety and the depression scale with global white matter (r = -0.74, p<0.05), parietal
white matter (r = -0.72, p<0.05) and temporal white matter water content (r = -0.78, p<0.05)
as well as the water content observed in the corpus callosum (r = -0.69, p<0.05) and in the pre-
cuneus (r = -0.74, p<0.05). Remaining associations were not significant.
Fig 1. Quantitative brain water content maps. Axial slices of water content maps obtained from a representative HD patient (a) and from an age-matched
healthy control (b). Differences between HD patients and healthy controls groups were assessed using non-parametric Wilcoxon rank-sum test and are
shown as an overlaid p-value map on a MNI template. Analyses of water content revealed increase of water content in predominantly white matter in HD
patients compared to controls. Hereby, enhanced brain hydration was found in particular in the parietal cortex, followed by occipital and fronto-temporal
regions (c). The color bar in a) and b) represents the water content in percent ranging from zero to hundred percent, the color bar in c) displays the p-values.
doi:10.1371/journal.pone.0122188.g001
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Discussion
This is the first in vivo quantitative study based on quantitative water content estimation re-
vealing evidence for abnormal brain water content mainly in white matter areas of cerebrum in
HD patients compared to healthy controls, as most likely long-term consequences of hemodial-
ysis. Based on current results, such changes on water content are likely to be accounted for
chronic or long-term disease factors, such as dialysis vintage, and less influenced by variations
during the dialysis cycle, as inferred by the lack of relevant interaction effects in our data. Al-
though few regions showed significant interactions, with a tendency of decreased water content
in HD patients after dialysis, whereas controls showed a marginal increase at re-test, similar to
previous studies [55], they might be likely related to method noise or error. Furthermore, one
of the major cognitive domains, altered in HD patients, namely attentional deficits, could be
linked to the increased frontal white matter water content.
Water in the human brain is located in distinctive microenvironments such as axons, neu-
rons, glial cells, myelin sheaths, extracellular space, and blood vessels. The water content mea-
surements for gray and white matter in our control group are in very good agreement with
Fig 2. Histogram. Distributions of the brain water content (X-axis) and T1 (Y-axis) from HD patients (red thin histogram lines before dialysis, thin green
histograms lines after dialysis) and healthy controls (blue thin histogram lines for first time point, black for second time point) are shown. Left: Individual data
and mean value histograms (bold) for T1 (Y-axis, left) reveal no significant differences in HD patients compared to healthy controls. Lower panel: Individual
data as well as mean value histograms (bold) for water content (X-axis) reveal increased white matter water content (~2%) as shown by the observed shift,
but only mild changes in gray matter in HD patients compared to controls.
doi:10.1371/journal.pone.0122188.g002
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Table 3. Estimated water content vales in the brain of hemodialysis patients and healthy controls on t1 and t2 time-points.
Anatomical region Hemodialysis Patients
(n = 10)
Healthy Controls (n = 10)
t1 t2 t1 t2
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mixed model
Global water content
White matter 72.89 (1.61) 73.48 (2.47) 71.46 (1.06) 71.67 (1.21) g*
Gray matter 84.42 (1.59) 84.15 (1.92) 82.93 (1.00) 83.62 (1.16) ns
White matter
Frontal lobe 72.31 (1.68) 72.98 (2.40) 70.89 (1.24) 71.14 (1.36) g*
Temporal lobe 72.23 (1.85) 72.96 (2.54) 70.52 (1.11) 70.71 (1.19) g*
Parietal lobe 72.36 (1.65) 72.90 (2.69) 70.97 (0.91) 71.04 (1.24) g*
Occipital lobe 73.06 (1.91) 73.64 (2.77) 71.59 (1.17) 71.76 (1.24) g*
Cerebellum 74.95 (1.19) 75.28 (2.41) 73.91 (0.82) 74.13 (1.09) ns
Gray matter
Frontal lobe 84.03 (1.38) 83.61 (2.07) 82.52 (1.00) 83.22 (1.39) ns
Temporal lobe 84.14 (1.85) 84.02 (2.00) 82.38 (1.08) 82.91 (1.07) g*
Parietal lobe 84.96 (2.27) 84.69 (2.27) 83.14 (1.31) 83.91 (1.18) ns
Occipital lobe 84.54 (1.58) 84.05 (1.93) 83.08 (0.93) 83.89 (1.11) i*
Cerebellum 84.77 (1.55) 84.86 (2.06) 83.73 (1.22) 84.29 (1.29) ns
Significant Subregions
Corpus callosum (body) 72.26 (2.15) 73.14 (2.82) 70.60 (1.11) 70.89 (1.22) g*
Frontal lobe
Inferior frontal gyrus pars triangularis (GM) 83.54 (1.51) 82.88 (1.89) 81.75 (1.09) 82.59 (1.47) i*
Inferior frontal gyrus pars opercularis (WM) 72.60 (1.50) 72.86 (2.30) 71.20 (1.65) 71.10 (1.40) g*
Frontal pole (GM) 82.79 (1.46) 82.37 (1.98) 81.47 (1.08) 82.35 (1.50) i*
Frontal operculum cortex (WM) 72.84 (1.68) 73.39 (2.69) 70.98 (1.41) 71.40 (1.61) g**
Temporal lobe
Superior temporal gyrus posterior division (WM) 72.73 (1.67) 73.60 (3.14) 71.30 (1.60) 71.57 (1.52) g*
Superior temporal gyrus anterior division (GM) 84.09 (2.19) 83.67 (2.25) 81.49 (1.44) 82.87 (1.49) g*, i*
Superior temporal gyrus posterior division (GM) 84.67 (1.49) 84.01 (1.84) 82.22 (1.70) 83.35 (1.42) g*, i*
Middle temporal gyrus temporooccipital part (WM) 73.41 (1.53) 73.94 (2.31) 71.69 (1.09) 71.91 (1.32) g*
Inferior temporal gyrus anterior division (WM) 71.70 (2.08) 72.61 (2.67) 70.73 (1.11) 71.93 (0.97) t**
Temporal pole (GM) 82.87 (1.39) 82.29 (2.01) 81.92 (1.18) 82.82 (1.34) i*
Temporal fusiform cortex posterior division (GM) 84.96 (1.81) 84.44 (2.00) 82.90 (1.05) 83.76 (1.04) g*
Hippocampus 85.83 (1.70) 85.42 (2.50) 83.79 (1.00) 84.50 (1.10) g*
Parahippocampal gyrus anterior division (GM) 84.26 (2.07) 82.85 (2.21) 82.79 (1.49) 83.46 (1.35) i*
Parahippocampal gyrus posterior division (WM) 74.98 (1.78) 75.41 (2.92) 73.15 (1.93) 72.93 (1.62) g*
Central opercular cortex (WM) 73.02 (1.71) 73.63 (2.77) 71.02 (1.19) 71.18 (1.36) g**
Central opercular cortex (GM) 84.52 (1.59) 84.47 (2.16) 82.50 (1.08) 83.20 (1.12) g*
Insular cortex (WM) 73.26 (1.92) 74.14 (2.92) 71.89 (1.37) 71.99 (1.30) g*
Parietal lobe
Postcentral gyrus (WM) 71.74 (1.57) 72.25 (2.38) 70.42 (1.32) 70.54 (1.36) g*
Supramarginal gyrus anterior division (WM) 72.55 (1.94) 73.13 (2.45) 71.05 (1.49) 71.03 (1.46) g*
Supramarginal gyrus anterior division (GM) 83.32 (1.75) 83.20 (1.73) 81.69 (1.08) 82.15 (1.16) g*
Supramarginal gyrus posterior division (WM) 72.29 (1.68) 73.19 (2.21) 70.75 (1.33) 70.87 (1.22) g*
Supramarginal gyrus posterior division (GM) 83.88 (1.78) 83.74 (1.72) 82.01 (1.20) 82.60 (0.99) g*
Precuneous cortex (WM) 72.52 (1.60) 73.50 (3.14) 71.24 (1.38) 71.19 (1.35) g*
Angular gyrus (WM) 72.30 (1.59) 73.05 (2.30) 70.49 (1.08) 70.74 (1.22) g**
(Continued)
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values from available neuroimaging literature (at 1.5T and 3T), including results from invasive
water content measurements in biopsy samples [14–16, 34, 36, 38, 56–59]. Changes in brain
water content and/or its spatial distribution, due to cerebral or extra-cerebral mediators, can
occur in both reversible and irreversible pathological conditions. Although we also revealed al-
terations of brain water content in the gray matter, quantitative water content maps results
mainly suggest a greater vulnerability of the white matter water content in HD patients. Simi-
larly and to greater extend, patients with hepatic encephalopathy showed an increase in cere-
bral white matter water content whereas water content in gray matter was globally unaffected
[14], indicating an increased susceptibility of this neural tissue. Nevertheless, our results show
an abnormal accumulation of excess fluid leading to early stage cerebral edema. As any cell,
glia, axon and myelin sheath can be the target of toxic substances and reactive astrocytes play a
significant role in cellular and tissue repair by detoxifying various noxious substances, excito-
toxic aspects leading to an (cytotoxic) edema may be involved. However, the increased uptake
of fluid results in local swelling, may compress the distinct microenvironments, which may fi-
nally result in dysfunctional states; and accompany various processes that damage cells, even in
the early phase of degeneration. Consequently, injured cells (neurons) can shrink and disinte-
grate, with time degeneration, and gliosis can develop. In this context, it has to be noted that—
although several neuroimaging studies in HD patients reported predominantly white matter at-
rophy, and to a lesser extent also in gray matter [60–66]—our sample showed only marginal
changes of reduced white matter volume.
However, being largest white matter fiber bundle in the human brain, containing more than
300 million axons, the corpus callosum showed an increase of brain water content in HD pa-
tients, which was associated with longer duration of dialysis vintage und lower intradialytic
weight change. Due to its highly interwoven connections the corpus callosum is integral in re-
laying sensory, motor, cognitive and emotional information between homologous regions in
the cerebral hemispheres. Consequently, abnormalities by water diffusion in the corpus callo-
sum may result in a broad variety of dysfunctions. The observed association between anxiety
Table 3. (Continued)
Anatomical region Hemodialysis Patients
(n = 10)
Healthy Controls (n = 10)
t1 t2 t1 t2
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mixed model
Angular gyrus (GM) 84.12 (1.74) 84.07 (1.87) 82.16 (1.07) 82.69 (0.96) g*
Parietal operculum cortex (GM) 84.33 (1.92) 84.60 (1.97) 82.42 (0.90) 83.16 (1.04) g*
Intracalcarine cortex (WM) 72.84 (1.81) 73.60 (2.86) 71.76 (1.42) 71.44 (1.50) g*
Supracalcarine cortex (GM) 84.61 (1.55) 84.54 (2.28) 82.83 (1.45) 83.42 (1.26) g*
Occipital lobe
Lateral occipital cortex superior division (WM) 72.00 (1.46) 72.50 (2.36) 70.21 (1.13) 70.35 (1.45) g*
Lateral occipital cortex superior division (GM) 83.55 (1.68) 83.50 (1.95) 81.62 (1.20) 82.13 (1.12) g*
Lateral occipital cortex inferior division (WM) 72.68 (1.68) 72.97 (2.73) 71.02 (0.83) 71.24 (1.30) g*
Occipital pole (GM) 84.09 (2.13) 83.90 (1.86) 82.16 (1.46) 82.97 (1.43) g*
Note. Mean and standard deviation values from patient and control groups, comparison of the two time points (before dialysis t1 vs. after dialysis t2). Data
are given in percentage of pure water molarity; WM = white matter; GM = gray matter, remaining subregions were not significant. ns, not significant; i,
significant interaction of group and time; g, significant main effect of group; t significant effect of time. Mixed linear model Group x Time.
* p <. 05
** p <. 01.
doi:10.1371/journal.pone.0122188.t003
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Fig 3. Association between brain water content and clinical parameters. Boxplots illustrating the association between water content in different focal
subregions and clinical parameters. Fig 3A suggests that increased water content in several white and gray matter regions is associated with longer dialysis
vintage. In Fig 3B the association between smaller intradialytic weight changes and increased water content in white and grey matter structures is shown.
doi:10.1371/journal.pone.0122188.g003
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and depression related to an increase in the corpus callosum water content corroborates the
previous findings of emotional dysregulation based on white matter abnormalities of the cor-
pus callosum affecting the limbic-cortical network [67].
Major areas of hydration alterations in HD compared to controls were also found in the pa-
rietal white matter. These could be in part linked to clinical variables. Our results are in accor-
dance with previous studies evoking the association between dialysis vintage and the presence
of cognitive impairment, and white matter abnormalities [64], which reinforces the idea that
longer dialysis vintage may add to an already increased vulnerability to repeated brain injury
and cognitive impairment [68], through several potential pathomechanisms. One of the factors
potentially involved is dialysis-related hypotension and associated changes in brain perfusion
and metabolism [69]. A study that investigated the role of intradialytic hypotension in brain at-
rophy in chronic HD patients, established a positive relation between the incidence of hypoten-
sive episodes during dialysis and the number of lacunae, but mainly focussed on the
association between hypotension and the progression of frontal lobe atrophy over three years
[62]. Although we could not establish a direct link to brain water content measures and damage
to fronto-subcortical areas, which are supposed to have an increased sensitivity to cerebrovas-
cular damage [69, 70], we hypothesize that the importance of frontal areas may be further em-
phasized by the link between water content in frontal areas and cognitive performance,
accentuating the significance of the frontal-attentional/executive domain in the cognitive dys-
function profile of patients undergoing hemodialysis [71–73]. This neuropsychological profile
of attentional and executive dysfunction was again observed in our sample, as we already de-
scribed in a larger sample [19].
Furthermore, alterations in the posteromedial portion of the parietal lobe and precuneus
resonate well with recent findings, that this region plays an essential role in multiple higher-
order cognitive processes [74]. Moreover, they are included in the brain structures with the
highest resting metabolic rates, and constitute a major part in the default mode network, which
is a high level or organized default functional activity at rest [75], and which can pinpoint dis-
tinct disease-specific alterations, such as in Alzheimer’s disease [76].
Also in line with previous studies is the observation of the association between anxiety and
depression and white matter, as well gray matter changes [77, 78], which might be mirrored
here with the increase of water content in white matter of the temporo-parietal cortex and the
corpus callosum.
This is the first in vivo study in HD investigating brain water content. We can state that
water homeostasis is altered in HD patients, most likely as chronic effect of hemodialysis, not
excluding the role of other factors. However, the results of this study and its interpretations are
limited due to the selected small-sized sample. Nevertheless, it reinforces the necessity to take
physiological values, as well as complementary metabolic imaging methods into account when
investigating brain alterations in this population.
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